What is the management approach for a patient with placenta previa undergoing a lower segment cesarean section (LSCS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Placenta Previa at Cesarean Section

Immediate Preoperative Preparation

All patients with placenta previa undergoing LSCS require delivery at a tertiary care facility with massive transfusion capabilities, multidisciplinary team coordination, and advance blood bank notification. 1

Critical Risk Assessment

  • Screen all patients with placenta previa and prior cesarean deliveries for placenta accreta spectrum disorder, as this dramatically increases surgical morbidity and mortality 1
  • The risk of placenta accreta increases 7-fold after one prior cesarean and up to 56-fold after three cesarean deliveries 1
  • Additional risk factors include anterior or central placental location, advanced maternal age (≥35 years), high parity, prior uterine surgery, and prior postpartum hemorrhage 1, 2
  • Transvaginal ultrasound is the diagnostic modality of choice for placental location assessment; MRI may be helpful for posterior placenta or suspected percreta 1

Multidisciplinary Team Assembly

Coordinate preoperatively with: 1

  • Maternal-fetal medicine subspecialists
  • Experienced pelvic surgeons (gynecologic oncology or urogynecology)
  • Urologic surgeons (for suspected bladder involvement)
  • Obstetric anesthesiologists
  • Interventional radiologists
  • Neonatologists
  • Blood bank personnel familiar with massive transfusion protocols

Optimize Maternal Status

  • Maximize hemoglobin values before delivery by treating anemia with oral or intravenous iron 1
  • Establish large-bore intravenous access for rapid fluid and blood product administration 3
  • Notify blood bank in advance due to frequent need for large-volume transfusion 1

Intraoperative Surgical Management

Surgical Approach

  • Inspect the uterus after peritoneal entry to determine placental location and optimize uterine incision placement 1
  • When possible, make the uterine incision away from the placenta 1
  • Consider dorsal lithotomy positioning to allow vaginal access and optimal surgical visualization 1
  • For suspected bladder involvement, consider ureteric stent placement preoperatively 1

Management of Placenta Accreta Spectrum

If placenta accreta spectrum is encountered, the most accepted approach is cesarean hysterectomy with the placenta left in situ. 1, 4

  • Never attempt forced placental removal, as this causes profuse hemorrhage 1, 4
  • After fetal delivery, leave the placenta in place if abnormal attachment is evident 1
  • Total hysterectomy is typically required because lower uterine segment bleeding frequently precludes supracervical hysterectomy 4
  • If fertility preservation is critically desired in focal accreta cases, conservative management may be considered, but this carries a 6% severe complication rate and 44% failure rate in percreta 4

Hemorrhage Control Strategies

Activate massive transfusion protocol early without waiting for laboratory results if significant bleeding occurs. 3

Blood Product Management

  • Transfuse in a fixed 1:1:1 ratio of packed red blood cells:fresh frozen plasma:platelets during massive hemorrhage 1, 3
  • Consider tranexamic acid to reduce blood loss 3
  • Monitor fibrinogen levels closely, as declining levels indicate consumption 3
  • Re-dose prophylactic antibiotics if blood loss exceeds 1,500 mL 1

Surgical Hemorrhage Control Techniques (if hysterectomy not immediately performed)

  • Intrauterine balloon tamponade with Sengstaken-Blakemore tube or Bakri balloon has shown 84% success in preventing hysterectomy for focal accreta 4, 5
  • Application of hemostatic fleece directly onto bleeding lower uterine segment surfaces 6
  • Uterine compression sutures 3
  • Hypogastric artery ligation 3
  • Pelvic packing 3
  • Interventional radiology embolization 3

Critical Intraoperative Monitoring

  • Maintain maternal temperature above 36°C, as clotting factors function poorly at lower temperatures 1, 3
  • Be vigilant for concealed vaginal hemorrhage, especially if hypotension persists despite apparent surgical field control 7
  • If binding the lower uterine segment with a tourniquet reduces surgical field bleeding but hypotension persists, immediately check for massive vaginal bleeding 7
  • Close monitoring of volume status, urine output, blood loss, and hemodynamics is critical 1, 4

Postoperative Management

Immediate Postoperative Care

  • Transfer to intensive care unit for severe cases given risks of ongoing bleeding, fluid overload, renal failure, liver failure, and disseminated intravascular coagulopathy 1, 3
  • Maintain intensive hemodynamic monitoring in the early postoperative period 1
  • Maintain a low threshold for reoperation if ongoing bleeding is suspected 1, 3

Complications Surveillance

Monitor for: 3

  • Ongoing hemorrhage
  • Renal failure
  • Liver failure
  • Infection/sepsis
  • Unrecognized ureteral, bladder, or bowel injury
  • Pulmonary edema
  • Disseminated intravascular coagulation
  • Sheehan syndrome (postpartum pituitary necrosis from hypoperfusion)

Follow-up

  • Ensure adequate iron supplementation and hemoglobin monitoring if significant blood loss occurred 1

Common Pitfalls to Avoid

  • Never perform digital pelvic examination until placenta previa has been excluded, as this can trigger catastrophic hemorrhage 1
  • Never attempt manual placental removal in suspected or confirmed placenta accreta spectrum 1, 4
  • Do not delay hysterectomy if hemorrhage cannot be quickly controlled; earlier hysterectomy correlates with better outcomes 7
  • Do not use methotrexate to hasten placental resorption in conservative management, as it has unproven benefit and possible harm 4
  • Do not wait for laboratory results before initiating transfusion protocols in active hemorrhage, as this significantly increases maternal morbidity 3

References

Guideline

Management and Treatment of Placenta Previa

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Morbidly adherent placenta previa in current practice: prediction and maternal morbidity in a series of 23 women who underwent hysterectomy.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2014

Guideline

Management of Placental Abruption

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Central Placenta Previa Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the most appropriate management for a 35-week pregnant patient with complete placenta previa, painless vaginal bleeding that has stopped, and who is hemodynamically stable?
What is the best course of action for a pregnant patient at 31 weeks gestation with placenta previa, moderate vaginal bleeding, hypotension, and tachycardia?
What is placental previa, its definition, risk factors, signs and symptoms, types, management, mode of delivery, and complications?
How do you manage a bleeding placenta previa during a cesarean section (c-section)?
How do you manage an oozing complete placenta previa at 32 weeks gestation with stable hemoglobin (Hb) and vital signs?
When to optimize vs switch to a different stimulant for a patient currently taking Vyvanse (lisdexamfetamine) 40 mg daily, according to the Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA) guidelines?
Is a double negative blood culture required for a patient with enterococcal bacteremia (blood infection) from cholecystitis (inflammation of the gallbladder) who has undergone cholecystectomy (surgical removal of the gallbladder) and has an isolate sensitive to ampicillin (antibiotic)?
What alternative to montelukast can be used for a patient with Postorgasmic Illness Syndrome (POIS) and Mast Cell Activation Syndrome (MCAS) who is at risk of depression?
What should a SOAP note include for a patient presenting with a rash?
Do any of the patient's medications, including Rena-Vite (B-Complex with C and Folic Acid), Acetaminophen, Eliquis (Apixaban), Calcitriol, Ferrous Sulfate, Milk of Magnesia (Magnesium Hydroxide), Vitamin C (Ascorbic Acid), Famotidine, Metoprolol Succinate, Mirtazapine, BPCO (Balsam Peru-Castor Oil), Lorazepam, Fleet Enema (Sodium Phosphates), Bisacodyl, ABH Gel (Ativan/Benadryl/Haldol), and Sodium Polystyrene Sulfonate, cause hyperkalemia?
What is the appropriate physical exam approach for an adult patient with abdominal pain and no significant past medical history?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.